DNDN, tangentially... I do think that this type of hyper-aware patient that tries to completely game the clinical trial system is the exception.</>
Patient groups in both the Nexavar RCC trial and the Sutent GIST trial cracked open the capsules and figured out by the color which were real and not. Never underestimate the ability of patients faced with death to work the system.
Incidentally, this was disclosed in a panel meeting with Pazdur in attendance and essentially meant the blind in the trial was broken from the very beginning. Both drugs were given full approval even though their SPAs said accelerated approval only on the initial surrogate endpoints.
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC